To include your compound in the COVID-19 Resource Center, submit it here.

Vividion and Celgene partner to develop small molecules

Vividion Therapeutics Inc. (San Diego, Calif.) and Celgene Corp. (NASDAQ:CELG) entered a four-year collaboration to discover and develop small molecules against

Read the full 211 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE